You are here: Industry Insights > Amphastar

News List

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection americanpharmaceuticalreview
May 07, 2021
Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration approved the company’s Abbreviated New Drug Application (“ANDA”) for Morphine Sulfate injection 1mg/mL in the 30mL Pump-Jet® Prefilled Syringe System.
Amphastar Receives FDA Approval for Dextrose Injection americanpharmaceuticalreview
March 30, 2021
Amphastar Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved the Company’s Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 mL Luer-Jet® Prefilled Syringe System.
US FDA approves Amphastar’s generic drug to treat severe hypoglycemia pharmaceutical-business-review
January 06, 2021
The US Food and Drug Administration (FDA) has approved the first generic drug produced by Amphastar Pharmaceuticals to treat severe hypoglycemia.
Amphastar Receives FDA Approval for Atropine Sulfate Injection americanpharmaceuticalreview
October 10, 2020
Amphastar Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved the Company’s Abbreviated New Drug Application (ANDA) for Atropine Sulfate injection 0.1mg/mL in the 10 mL Luer-Jet® Prefilled Syringe System.
Amphastar Receives FDA Approval for Supplement to ANDA for Sodium Bicarbonate Injection americanpharmaceuticalreview
March 05, 2020
Amphastar Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) granted approval of its supplemental Abbreviated New Drug Application for Sodium Bicarbonate Injection ...